Crossmark Global Holdings, Inc. Bio Rad Laboratories, Inc. Transaction History

Crossmark Global Holdings, Inc.

  • $5.61 Billion
  • Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 1,227 shares of BIO stock, worth $419,032. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,227
Previous 1,822 32.66%
Holding current value
$419,032
Previous $498,000 17.47%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$263.97 - $344.64 $157,062 - $205,060
-595 Reduced 32.66%
1,227 $411,000
Q2 2024

Jul 29, 2024
BUY
$268.26 - $339.48 $26,021 - $32,929
97 Added 5.62%
1,822 $498,000
Q1 2024

May 13, 2024
SELL
$304.11 - $351.99 $46,224 - $53,502
-152 Reduced 8.1%
1,725 $597,000
Q4 2023

Feb 13, 2024
SELL
$269.37 - $365.04 $8,081 - $10,951
-30 Reduced 1.57%
1,877 $606,000
Q3 2023

Nov 08, 2023
BUY
$350.25 - $422.63 $7,355 - $8,875
21 Added 1.11%
1,907 $696,000
Q2 2023

Jul 31, 2023
SELL
$359.49 - $486.4 $102,454 - $138,624
-285 Reduced 13.13%
1,886 $786,000
Q1 2023

May 12, 2023
SELL
$418.69 - $503.0 $108,022 - $129,774
-258 Reduced 10.62%
2,171 $1.04 Million
Q4 2022

Jan 19, 2023
BUY
$351.71 - $456.01 $129,429 - $167,811
368 Added 17.86%
2,429 $1.02 Million
Q3 2022

Nov 01, 2022
SELL
$412.59 - $563.26 $46,210 - $63,085
-112 Reduced 5.15%
2,061 $859,000
Q2 2022

Jul 29, 2022
BUY
$463.67 - $597.16 $125,190 - $161,233
270 Added 14.19%
2,173 $1.08 Million
Q1 2022

May 11, 2022
SELL
$524.57 - $735.42 $78,685 - $110,313
-150 Reduced 7.31%
1,903 $1.07 Million
Q4 2021

Jan 10, 2022
SELL
$708.84 - $794.68 $1.88 Million - $2.11 Million
-2,650 Reduced 56.35%
2,053 $1.55 Million
Q3 2021

Oct 21, 2021
BUY
$657.71 - $825.77 $3.09 Million - $3.88 Million
4,703 New
4,703 $3.51 Million
Q3 2021

Oct 13, 2021
SELL
$657.71 - $825.77 $3.33 Million - $4.18 Million
-5,063 Closed
0 $0
Q2 2021

Jul 21, 2021
SELL
$576.64 - $649.04 $80,729 - $90,865
-140 Reduced 2.69%
5,063 $3.26 Million
Q1 2021

Apr 15, 2021
SELL
$547.01 - $662.35 $437,608 - $529,880
-800 Reduced 13.33%
5,203 $2.97 Million
Q4 2020

Jan 14, 2021
BUY
$510.68 - $643.45 $1.82 Million - $2.29 Million
3,560 Added 145.72%
6,003 $3.5 Million
Q3 2020

Oct 08, 2020
BUY
$454.43 - $535.6 $181,772 - $214,240
400 Added 19.58%
2,443 $1.26 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $73,001 - $107,487
218 Added 11.95%
2,043 $922,000
Q1 2020

Apr 28, 2020
SELL
$320.01 - $409.07 $22,400 - $28,634
-70 Reduced 3.69%
1,825 $639,000
Q4 2019

Feb 06, 2020
SELL
$319.73 - $374.2 $127,892 - $149,680
-400 Reduced 17.43%
1,895 $701,000
Q3 2019

Oct 09, 2019
SELL
$304.55 - $345.24 $31,673 - $35,904
-104 Reduced 4.34%
2,295 $764,000
Q2 2019

Jul 09, 2019
SELL
$286.93 - $312.59 $40,744 - $44,387
-142 Reduced 5.59%
2,399 $750,000
Q1 2019

May 02, 2019
BUY
$224.3 - $317.41 $24,673 - $34,915
110 Added 4.52%
2,541 $777,000
Q4 2018

Jan 31, 2019
SELL
$220.1 - $309.0 $88,480 - $124,218
-402 Reduced 14.19%
2,431 $565,000
Q3 2018

Nov 08, 2018
SELL
$289.28 - $326.15 $44,259 - $49,900
-153 Reduced 5.12%
2,833 $887,000
Q2 2018

Jul 31, 2018
SELL
$244.1 - $303.88 $47,355 - $58,952
-194 Reduced 6.1%
2,986 $862,000
Q1 2018

Apr 16, 2018
SELL
$233.97 - $274.11 $96,395 - $112,933
-412 Reduced 11.47%
3,180 $795,000
Q4 2017

Feb 05, 2018
SELL
$216.94 - $271.3 $96,538 - $120,728
-445 Reduced 11.02%
3,592 $857,000
Q3 2016

Oct 25, 2017
BUY
N/A
4,037
4,037 $897,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email